Drug Shortage Report for MYLAN-HYDROXYCHLOROQUINE
| Report ID | 5925 |
| Drug Identification Number | 02252600 |
| Brand name | MYLAN-HYDROXYCHLOROQUINE |
| Common or Proper name | HYDROXYCHLOROQUINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROXYCHLOROQUINE SULFATE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100BT |
| ATC code | P01BA |
| ATC description | ANTIMALARIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-07-03 |
| Actual start date | 2018-07-03 |
| Estimated end date | Unknown |
| Actual end date | 2018-07-03 |
| Shortage status | Resolved |
| Updated date | 2018-07-05 |
| Company comments | Discontinued in ID 44856 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.